Oak Street Health, Inc.
OSH · NYSE
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $2,160,900 | $1,432,600 | $882,765 | $556,604 |
| % Growth | 50.8% | 62.3% | 58.6% | – |
| Cost of Goods Sold | $2,082,800 | $1,402,700 | $805,355 | $526,851 |
| Gross Profit | $78,100 | $29,900 | $77,410 | $29,753 |
| % Margin | 3.6% | 2.1% | 8.8% | 5.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $344,800 | $306,700 | $185,495 | $79,592 |
| SG&A Expenses | $509,100 | $426,100 | $249,706 | $125,781 |
| Sales & Mktg Exp. | $164,300 | $119,400 | $64,211 | $46,189 |
| Other Operating Expenses | $35,200 | $17,800 | $11,225 | $7,848 |
| Operating Expenses | $544,300 | $443,900 | $260,931 | $133,629 |
| Operating Income | -$466,200 | -$414,000 | -$183,521 | -$103,876 |
| % Margin | -21.6% | -28.9% | -20.8% | -18.7% |
| Other Income/Exp. Net | -$43,300 | -$2,500 | -$8,556 | -$5,567 |
| Pre-Tax Income | -$509,500 | -$416,500 | -$192,077 | -$109,443 |
| Tax Expense | $200 | -$1,900 | $4,781 | $4,154 |
| Net Income | -$509,700 | -$414,600 | -$196,858 | -$113,597 |
| % Margin | -23.6% | -28.9% | -22.3% | -20.4% |
| EPS | -2.21 | -1.86 | -0.9 | -0.56 |
| % Growth | -18.8% | -106.7% | -60.7% | – |
| EPS Diluted | -2.21 | -1.86 | -0.9 | -0.56 |
| Weighted Avg Shares Out | 230,133 | 222,553 | 218,825 | 204,098 |
| Weighted Avg Shares Out Dil | 230,133 | 222,553 | 218,825 | 204,098 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $2,500 | $2,500 | $8,712 | $5,651 |
| Depreciation & Amortization | -$5,600 | $17,800 | $11,381 | $7,932 |
| EBITDA | -$471,800 | -$396,200 | -$172,140 | -$95,944 |
| % Margin | -21.8% | -27.7% | -19.5% | -17.2% |